Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In Vitro CYP450 Enzyme Downregulation by GLP-1/Glucagon Coagonist Does Not Translate to Observed Drug-Drug Interactions in the Clinic
Carolina Säll, Lene Alifrangis, Kirsten Dahl, et al.
Drug Metabolism and Disposition (2022) Vol. 50, Iss. 8, pp. 1087-1097
Open Access | Times Cited: 10

Showing 10 citing articles:

Results from three phase 1 trials of NNC9204-1177, a glucagon/GLP-1 receptor co-agonist: Effects on weight loss and safety in adults with overweight or obesity
Martin Friedrichsen, Lars Endahl, Frederik Flindt Kreiner, et al.
Molecular Metabolism (2023) Vol. 78, pp. 101801-101801
Open Access | Times Cited: 24
3D Spheroid Primary Human Hepatocytes for Prediction of Cytochrome P450 and Drug Transporter Induction
Erkka Järvinen, Helen Hammer, Oliver Pötz, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 113, Iss. 6, pp. 1284-1294
Open Access | Times Cited: 16
Industry Perspective on Therapeutic Peptide Drug–Drug Interaction Assessments During Drug Development: A European Federation of Pharmaceutical Industries and Associations White Paper
Carolina Säll, Upendra A. Argikar, Kari R. Fonseca, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 113, Iss. 6, pp. 1199-1216
Open Access | Times Cited: 13
In‐Depth Analysis of the Selection of PBPK Modeling Tools: Bibliometric and Social Network Analysis of the Open Systems Pharmacology Community
André Dallmann, Donato Teutonico, Stephan Schaller, et al.
The Journal of Clinical Pharmacology (2024) Vol. 64, Iss. 9, pp. 1055-1067
Open Access | Times Cited: 3
Assessment of the drug–drug interaction potential for therapeutic proteins with pro‐inflammatory activities
Yanke Yu, Charity Henrich, Diane Wang
Clinical and Translational Science (2023) Vol. 16, Iss. 6, pp. 922-936
Open Access | Times Cited: 8
Glucagon/GLP-1 receptor co-agonist NNC9204-1177 reduced body weight in adults with overweight or obesity but was associated with safety issues
Martin Friedrichsen, Lars Endahl, Frederik Flindt Kreiner, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 13
Enzyme-mediated drug-drug interactions: a review of in vivo and in vitro methodologies, regulatory guidance, and translation to the clinic
Jaydeep Yadav, Benjamin J. Maldonato, Joseph M. Roesner, et al.
Drug Metabolism Reviews (2024), pp. 1-33
Closed Access | Times Cited: 1
Pharmacokinetics and Safety of Cotadutide, a GLP-1 and Glucagon Receptor Dual Agonist, in Individuals with Renal Impairment: A Single-Dose, Phase I, Bridging Study
G. Klein, Marcella Petrone, Ye Yang, et al.
Clinical Pharmacokinetics (2023) Vol. 62, Iss. 6, pp. 881-890
Open Access | Times Cited: 2
3D Spheroid Primary Human Hepatocytes for Prediction of Cytochrome P450 and Drug Transporter Induction
Erkka Järvinen, Helen Hammer, Oliver Pötz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Prediction of CYP Down Regulation after Tusamitamab Ravtansine Administration (a DM4‐Conjugate), Based on an In Vitro–In Vivo Extrapolation Approach
Clemence Pouzin, Donato Teutonico, Nathalie Fagniez, et al.
Clinical Pharmacology & Therapeutics (2023)
Open Access
Page 1

Scroll to top